FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerFKBP51 and FKBP52 in signaling and diseaseLarge FK506-Binding Proteins Shape the Pharmacology of RapamycinNeoplasia: the second decade.Statistics of protein-DNA binding and the total number of binding sites for a transcription factor in the mammalian genome.Astrocytes derived from trisomic human embryonic stem cells express markers of astrocytic cancer cells and premalignant stem-like progenitorsPhase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse modelFKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.InterAKTions with FKBPs--mutational and pharmacological exploration.Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in ratsYeast functional screen to identify genes conferring salt stress tolerance in Salicornia europaeaCoupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor ProteinsFKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma.Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomicsThe cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosisAn NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomasExpression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapyMicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathwaysThe story of human cytomegalovirus and cancer: increasing evidence and open questions.The War on Cancer rages on.The emerging role of large immunophilin FK506 binding protein 51 in cancerBiological relevance of Hsp90-binding immunophilins in cancer development and treatment.Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasisChecks and balances: The glucocorticoid receptor and NFĸB in good times and bad.FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone.A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma.Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy.FK506-binding protein 51 is a possible novel tumoral marker.FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function.Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides.The prospect of FKBP51 as a drug target.Low-frequency nonsynonymous variants in FKBPL and ARPC1B genes are associated with breast cancer risk in Chinese women.
P2860
Q24628746-91DB3CF2-FACE-401A-910D-FD0488AC7832Q26861304-0A37A616-80CE-4F2F-8418-9413927430CAQ27676039-1D3BA149-549D-43C9-9ABE-7CE885DB0B1EQ30484000-9C2D295D-F234-4FEF-A78F-13F07F3A7915Q33531514-A48ED4B7-D2C9-4200-B5BA-51F3CBD25BA0Q33566348-A7D940BF-EF63-437A-B0D3-81746D071BD8Q33747609-A122E2BD-2B8F-4A98-B7FC-1F7EFD4E08A6Q34049326-46ABBAEE-5F9D-42F5-A056-F1E3CEE96F66Q34580343-9199230A-B1B7-45CF-8E74-D3E18B0AC90DQ34612149-2E3E6B70-8286-4ED9-847C-53C1075AC429Q35085333-AAA80803-EA75-4111-9390-ADC4CC6D2D5DQ35844708-41BC71E3-5B00-464E-97C4-8D1E505F98C5Q35860705-424194F3-8C7C-4D61-970A-577D64AC6183Q35961896-C3C21402-EA6B-4959-9550-8538FD626B57Q36104523-457D31B1-FA6C-424F-8E7F-3FCACC45C5D7Q36186374-8924EF6E-1BE3-49A9-A6CE-667C8BE15AC1Q37078019-979760FF-F7FD-4E8B-8962-E20C9E5B32BBQ37108510-758E321A-2975-459C-90A5-D1116016FC88Q37235553-538D4E19-8B71-4CB4-BAEC-CA878C340FB4Q37357932-CBAD8499-9E00-4CE4-A466-16479A5B2075Q37478602-AF5EAF78-058E-4BAB-8AC2-4432CE139E99Q37956712-18170970-5E87-4975-A094-8378BCFBF6A6Q38371280-E5F2EE99-B846-4798-BB0E-56127199994DQ38827878-2448A22B-C0BC-473D-A89D-9B51D8A665FEQ38878910-7C1C1650-FA40-41DE-A492-1E7BC87225A6Q39305340-36491941-E3CC-44F0-884D-69F2523A40A9Q41640775-C1CCB36B-6F20-45E7-8FF6-644C7B5A35B7Q42011685-806B0C18-F9EF-492D-B674-6AB54D3A75A7Q42172477-C40EB4A6-793A-45AE-BDFD-0D1726F625ECQ42588201-C982FB2C-41AE-4065-BF55-92B73058737FQ47112399-E4E72EA4-653D-429D-BAAB-67377642043CQ47160893-0D11C149-86DA-44E3-B08F-33D4E0FCB704Q47699242-1F82601F-88C2-484C-8AFB-B63744B526E2Q48682440-DD125E13-BA88-4DEA-B1D8-7F6FDE7F7D03Q51457150-868A9F85-95B2-464C-A488-C6C45E173B02
P2860
FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
FK506 binding protein mediates ...... ng NF-kappaB signaling pathway
@ast
FK506 binding protein mediates ...... ng NF-kappaB signaling pathway
@en
type
label
FK506 binding protein mediates ...... ng NF-kappaB signaling pathway
@ast
FK506 binding protein mediates ...... ng NF-kappaB signaling pathway
@en
prefLabel
FK506 binding protein mediates ...... ng NF-kappaB signaling pathway
@ast
FK506 binding protein mediates ...... ng NF-kappaB signaling pathway
@en
P2093
P2860
P356
P1433
P1476
FK506 binding protein mediates ...... ng NF-kappaB signaling pathway
@en
P2093
Brock Armstrong
Cunli Xiang
Howard A Fine
Jean C Zenklusen
Michael Berens
Simona Cazacu
Tom Mikkelsen
P2860
P304
P356
10.1593/NEO.07929
P577
2008-03-01T00:00:00Z